A recent study in mice reveals that treatment using an antibody, called anti-CD137, enhances the immune system’s response against multiple myeloma tumors. The positive results of this preclinical study suggest that anti-CD137, a type of cancer immunotherapy, may be suitable for use in human multiple myeloma patients.

Cancer immunotherapy helps the immune system fight cancer.  It has emerged in recent years as an alternative to high-dose chemotherapy and stem cell transplantation treatments.

Following a dose of chemotherapy, …

Overview

Multiple myeloma, like most medical conditions, manifests itself slightly differently in each patient. Because multiple myeloma can affect many organs, several possible symptoms exist, and they vary greatly. No sign or symptom is a direct indicator of multiple myeloma. Any symptom may be due to other causes, and multiple myeloma may initially cause no symptoms at all.

Multiple myeloma occurs when cancerous myeloma cells collect in many bones, unlike a plasmacytoma, which only involves a solid tumor in one …